44 /100
MEDIUM RISK
Score updated Jul 14, 2026

LAES — SEALSQ Corp Dilution Risk Tracker

Track LAES dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LAES — Get alerts when the score changes →

As of July 14, 2026, SEALSQ Corp (LAES) has a DilutionWatch DilutionScore of 44/100, rated MEDIUM dilution risk. SEALSQ Corp has a market capitalization of $775.25M, 191.53M shares outstanding, 10 institutional holders tracked. Key dilution vectors include approximately 164 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for LAES.
🔔 Track LAES — Get forecast alerts →

💹 Market Data

Market Cap$775.25M
Shares Outstanding191.53M
Float171.76M
Cash$427.69M
Debt$1.68M
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 20.48M shares
#1 Anson Funds Management LP 12.46M shares
#2 Heights Capital Management, Inc 3.14M shares
#3 Susquehanna International Group, LLP 1.32M shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest13.88M
Days to Cover1.0
% of Float8.1%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jun 30, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2024
4 INSIDER TRANSACTION Jul 08, 2026
4 INSIDER TRANSACTION Jun 18, 2026
4 INSIDER TRANSACTION Jun 05, 2026
Full SEC filing analysis available with free account

📰 Recent News

📋 What This Means for LAES Shareholders

SEALSQ Corp (LAES) has a DilutionScore of 44/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for LAES shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for LAES in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for LAES alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track LAES Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LAES — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for LAES
📊 LAES FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 LAES Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.